Connect Sign In
ARUP scientists authored more than 130 peer-reviewed publications and presented at over 100 conferences in 2025, highlighting a year of research, innovation, and progress in diagnostic medicine.
ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.
ARUP has built a comprehensive pediatric test menu and paired it with research, education, and expert consultation to help care teams make informed decisions for children.
James Hadley, CISSP, chief information security officer, brings 25 years of cybersecurity experience to ARUP with a focus on risk management, collaboration, and building a resilient security culture.
In his new role, Adam Barker, PhD, will lead operational innovation to support ARUP’s growth while maintaining the highest quality.
Paul’s life was saved thanks to 12 generous blood donors, demonstrating the power of community and compassion.
The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community.
Jonathan Genzen, MD, PhD, MBA, ARUP chief medical officer and senior director of governmental affairs, is taking the mic of the LabMind podcast and continuing its legacy of insightful conversations.
The Utah NeoSeq Project, a collaboration between ARUP Laboratories and University of Utah Health, is transforming neonatal care using rapid whole genome sequencing (rWGS).
Mei San Tang, MD, is aligning science, community, and care to elevate ARUP’s blood banking and deliver precision and compassion where it matters most.
